Li 2005.
Methods | Six‐week, (likely) randomised study. |
Participants | Out‐patients with depression according to CCMD‐III criteria. |
Interventions | Citalopram: 25 participants. Venlafaxine: 25 participants. Citalopram dose‐range: 20‐40 mg/day. Venlafaxine dose‐range: 25‐250 mg/day. |
Outcomes | Change in Hamilton Depression Rating Scale (HDRS) from baseline to endpoint, number of patients who responded to treatment, number of patients who remitted. |
Notes | Waiting for translation from Chinese to English (only abstract available in English). |